Clinical Trial Update: Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for metastatic breast cancer evaluating a vaccine therapy in combination with the IDO pathway inhibitor 1-MT; the phase 1/2 study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer

Drugs mentioned

• 1-Methyltryptophan (1-methyl-tryptophan)
• Vaccine therapy

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-05